The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful responses to a disease.

South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work.

With recent cuts to foreign aid, including programs like PEPFAR, thousands of Africans living with HIV face an uncertain future. Although the freeze was followed by an exemption for “life-saving treatments,

South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work. The first round of vaccines she and her colleagues made in Johannesburg had produced an immune response in rabbits,

At a rural village in South Africa's KwaZulu-Natal province, unemployed 19-year-old Nozuko Majola is trying to figure out if she has enough money for the one-hour ride to collect her much-needed HIV medication,

HIV infections and deaths would increase dramatically should the United States cut back on funding for the President’s Emergency Plan for AIDS Relief (PEPFAR).